US 5,175,264 A · 5-[4-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid

Abstract

This invention relates to 5-[4-[-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid (DISALAZINE) is provided as a new compound having anti-arthritic and immunomodulating properties. It can be produced via reaction of the diazonium salt of sulfadimidine reacted with salicylic acid and then acetylating the product anti-arthritic and immunomodulating properties.

Claims1

Dependent claims

5-[4-(4,6-dimethyl-2-pyrimidinylsulfamoyl/phenylazo] acetylsalicylic acid, of the formula ##STR2##

Dependencies are inferred from the claim text.

Facts

Application

07/776,081Filed 11 Oct 1991

Priority

CS 1426-9115 May 1991

Granted

29 Dec 1992

Term ends

Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07D 239/69
With hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon…
A61P 1/04
Drugs for disorders of the alimentary tract or the digestive system: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of…
A61P 29/00
Non-central analgesic, antipyretic or antiinflammatory agents
A61P 37/00
Drugs for immunological or allergic disorders

5-[4-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid

Life of this patent

Abstract

Claims1

5-[4-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid

Life of this patent

Abstract

Claims1